Atrial fibrillation and prevention of thromboembolism

Authors

  • Paulo Ascensão Assistente Graduado de Clínica Geral/Medicina Familiar Administração Regional de Saúde do Alentejo Sub-Região de Saúde de Beja Centro de Saúde de Ourique

DOI:

https://doi.org/10.32385/rpmgf.v22i1.10205

Keywords:

Médicos Sentinela, Atrial fibrilation, Embolic risk, Anti-coagulation, CHADS2

Abstract

Aim: To determine the prevalence of atrial fibrillation (AF) in the population of patients attending the Portuguese Sentinel Network; to characterize the therapeutical options adopted in the AF patients and to evaluate patients embolic risk. Methods: Descriptive cross-sectional study in Portugal, 2003. A total of 67.654 patients of 43 family physicians were included in the study sample. Each doctor reported the number of AF patients diagnosed in their practice. Other study variables were: sex, age, previous attempt of cardioversion, co-morbidity, and pharmacological treatment used. Results: Three hundred and fifty nine patients were reported as AF cases. No case was reported under the age of 34, thus the prevalence calculated over this age was 0,94%. Within the AF patients, 84,1% are present cases and 14,5% past cases (paroxistic or sinus rhythm successful conversion). Digoxin was the therapeutical option in 25,8% of patients, and amiodarone in 24,8%. Discussion: Antiarrhythmic therapeutical use in these AF Portuguese patients is not accordingly with international guidelines. We do not know, however, if there was an underlying clinical explanation for the prescription options found in this population.

Downloads

Download data is not yet available.

Downloads

Published

2006-01-01

Issue

Vol. 22 No. 1 (2006): Revista Portuguesa de Clínica Geral

Section

Original Research

License

The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.

The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.

 

How to Cite

Atrial fibrillation and prevention of thromboembolism. (2006). Portuguese Journal of Family Medicine and General Practice, 22(1), 13-24. https://doi.org/10.32385/rpmgf.v22i1.10205

Most read articles by the same author(s)